- AN ANTI-CELL-SENESCENCE COMPOSITION
Patent date Issued Aug 13, 2020 Patent issuer and number au WO2020160618
Patent description The present invention relates to pharmaceutical compositions comprising a therapeutically effective dose of each of fisetin, quercetin, an extract of Schinopsis sp., a Fragaria sp. extract, and a tocotrineol, and the use of these in a method of mitigating a condition associated with cell senescence.
See patent AN ANTI-CELL-SENESCENCE COMPOSITION See patent
- Patent title EPIGENETIC DRIFT - ATTENUATING
Patent date Issued Aug 13, 2020 Patent issuer and number au WO2020160620
Patent description As animals, including humans, age, epigenetic changes to the DNA lead to methylation of the cytosines in the CpG islands, but also methylation of other nucleotides. Epigenetic changes are associated with the development of ageing-related cell and tissue dysfunction, and patient morbidities within the ageing populations world-wide. Given the afore-mentioned dysfunction and morbidities within the ageing populations around the world, a need exists for a composition that will attenuate epigenetic drift when administered in a therapeutically effective dose to a subject in need thereof and a method of using such a composition. The present disclosure relates to an epigenetic drift attenuating composition comprising green tea extract, apigenin, betaine, choline, curcumin, epigallocatechin, folic acid, genistein, lycopene, quercetin, resveratrol, selenium, sulforaphane, and vitamin B12 and a method of use thereof.
See patent EPIGENETIC DRIFT – ATTENUATING See patent
- Patent title PROMOTION OF KLOTHO PROTEIN
Patent date Issued May 2, 2020 Patent issuer and number au WO2020160617
Patent description Dysfunctional protein production is associated with the development of morbidities related to tissue damage that accumulates with age and a need exists for a composition that will mitigate an effect of ageing when administered in a therapeutically effective dose to a subject in need thereof and a method of using such a composition. Provided is a composition including a therapeutically effective dose of each of actin, a green tea extract, sulphoraphane, γ-aminobutyric acid (GABA), an omega-3 fatty acid, a Cordyceps sinensis extract, zinc, a Centaurea cyanus extract, cholecalciferol, ergocalciferol, magnesium, and resveratrol, the composition formulated to mitigate a condition associated with a reduction in Klotho protein production and/or distribution of a subject and a method of use thereof.
See patent PROMOTION OF KLOTHO PROTEIN See patent
- Patent title MENS HEALTH PILL
Patent date Issued Jan 9, 2020 Patent issuer and number au WO2020006606A1
Patent description The present disclosure relates to a pharmaceutical composition in a pharmaceutically acceptable vehicle. The pharmaceutical composition includes a physiologically effective, non-priapismic, dose of a penile-erection-inducing agent or a pharmaceutically acceptable addition salt thereof and a physiologically effective dose of an orgasm-delaying agent or a pharmaceutically acceptable addition salt thereof. The disclosed pharmaceutical composition may be useful in the treatment of erectile dysfunction and premature ejaculation.
See patent MENS HEALTH PILL See patent
- Patent title A RESPIRATORY PASSAGE SPRAYER AND METHOD OF USE OF SAME
Patent date Issued Sep 23, 2019 Patent issuer and number au WO2020069559
Patent description Mixing of substances is known to increase, in some cases, lability of one or more of the constituent molecules in the mixture. In some cases, such admixture of substances may lead, in addition to instability of one or more molecules, to decomposition of labile molecules. Such instability and/or decomposition may be due to concentration effects, enzymatic action, heat, light, a redox reaction, other components in the same solution reacting with labile molecules, physicochemical factors such as pH, and/or solvent effects. It will be appreciated that a lack of stability of a molecule represents a major cause for concern in medical chemistry. The present disclosure relates to a respiratory passage sprayer for administration of substances to a subject and a method of use of the respiratory passage sprayer.
See patent A RESPIRATORY PASSAGE SPRAYER AND METHOD OF USE OF SAME See patent
- Patent title A TOPICAL SKIN CREAM COMPOSITION
Patent date Issued Jul 25, 2019 Patent issuer and number au WO2020019034
Patent description The present disclosure relates to a topical skin cream composition that adds a human specific telomere repeat sequence to a 3' end of a human telomere to assist with the rejuvenation of human skin. It will be readily appreciated that a topical skin cream composition, which may be understood to include a body cream, a body lotion, a body mask, a cold cream, a concealing cream, an eye cream, a facial mask, Galen's wax, a lip balm, a moisturiser for skin, a toning lotion, a vanishing cream, and any other pharmaceutical cream suitable for application to human skin, that can rejuvenate human skin will benefit those interested in maintaining a healthy skin that is youthful insofar as possible with minimal deleterious effects due to the course of time and concomitant exposure to stressors.
See patent A TOPICAL SKIN CREAM COMPOSITION See patent
- Patent title CONTAINER FOR AMYLASE INHIBITOR
Patent date Issued Jul 25, 2019 Patent issuer and number au WO2020019033
Patent description The present disclosure relates to a container within which at least one amylase inhibitor is stored, this container has a lid or cap that includes one or more apertures from which the inhibitor can exit the container. The inhibitor may be in either a divided form, for example crystals or particulate matter, a liquid, or a semi-liquid form.
See patent CONTAINER FOR AMYLASE INHIBITOR See patent
- Patent title BARRIER FLUID FOR THE SKIN
Patent date Issued Jul 25, 2019 Patent issuer and number au WO2020019031
Patent description The present disclosure relates to a liquid or semi-liquid that is applied to the skin using a transfer medium, an absorbent wipe for example, or directly, spray for example, which results in a barrier layer being formed on the skin surface. The liquid or semi- liquid is formulated to facilitate the removal of any contaminants that impinge on the barrier layer. The barrier layer formed on the skin surface may have a non-stick exposed surface.
See patent BARRIER FLUID FOR THE SKIN See patent
- Patent title OPTICAL ARTERIAL PATHWAY THERAPY
Patent Nov 23, 2018 Patent issuer and number au US20190038909; WO2017136891; EP3413973; CN108883293
Patent description Methods and devices for delivering electromagnetic radiation for therapeutic purposes are provided herein. The methods and devices include contacting blood with electromagnetic radiation, preferably by an optical fibre. The methods and devices are particularly suitable for intra-arterial irradiation of a treatment site of a subject.
See patent OPTICAL ARTERIAL PATHWAY THERAPY See patent
- MELANIN PRODUCTION STIMULATING DEVICE – SOLARIUM WITH NO UV
Patent date Issued Oct 10, 2018 Patent issuer and number au WO2019084600
Patent descriptionA device for stimulating the production of melanin. The device includes an electromagnetic radiation generator, an interface configured to select at least one of a visible light and infrared light, an ultrasound generator, and a second interface configured to selectively adjust a frequency of the ultrasound generator. Also provided is a method of using the device disclosed herein
See patent MELANIN PRODUCTION STIMULATING DEVICE - SOLARIUM WITH NO UV See patent
- Pa tent title PHOTOBANDAGE A THERAPEUTIC DEVICE
Patent date Issued Nov 14, 2017 Patent issuer and number au WO2018085901
Patent description A phototherapeutic bandage configured to conform to a surface area of a wearer. The bandage includes a first layer with an electroluminescent light source adapted to emit radiation to a portion of a target area of a user, and a second layer having a source configured to emit radiation at a wavelength in the far-infrared radiation range to the target area, or portion thereof.
See patent PHOTOBANDAGE A THERAPEUTIC DEVICE See patent
- Patent title SLEEPING ACCESSORY
Patent date Issued Nov 9, 2017 Patent issuer and number au WO2018085887
Patent description A sleeping accessory for holding a person's legs in alignment with each other. The accessory includes a body with holding formations, and, optionally, a fastening strap to fasten the accessory to the user. The accessory may include one or more sensors and wireless radios configured to provide sleep data.
See patent SLEEPING ACCESSORY See patent
- Patent title A HEARING LOSS ALLEVIATING DEVICE
Patent date Issued Jul 27, 2017 Patent issuer and number au WO2018018085
Patent description A hearing loss alleviating device sized and configured to be received, at least in part, by a central auditory system of a subject and a method of using the same. The hearing loss alleviating device includes a power supply and at least one of an electromagnetic radiation generator, an electromagnetic field generator, and a high frequency sound generator. When powered, the hearing loss alleviating device generates at least one of electromagnetic radiation, an electromagnetic field, and high frequency sound.
See patent A HEARING LOSS ALLEVIATING DEVICE See patent
Patent date Issued Jun 1, 2017 Patent issuer and number au WO2017205922
Patent description A garment, particularly in the form of a brassiere, described herein that includes a breast covering portion sized and configured to receive a breast of a wearer; and an electromagnetic radiation source facing inwardly towards the skin of the wearer, the electromagnetic radiation source configured to irradiate a portion of a breast and being positioned along a portion of the breast covering portion. Also described are methods of delivering electromagnetic radiation, and methods of treatment using the brassiere.
See patent A GARMENT See patent
- Patent title SYSTEM AND METHOD FOR IRRADIATING HUMAN SKIN
Patent date Issued Jun 10, 2016 Patent issuer and number au AU2016231537
Patent description A device for selectively irradiating at least one layer of human skin. The device includes a housing with at least two electrodes, a with at least one aperture, and a filter holder configured to hold at least two different filters. The filter holder is in moveable engagement relative to the housing to at least partially obscure the housing aperture so that light emitted from an arc between the electrodes passes through the aperture and through at least a portion of a filter held by the filter holder.
See patent SYSTEM AND METHOD FOR IRRADIATING HUMAN SKIN See patent
- Patent title A GLYCATION REDUCING COMPOSITION
Patent issuer and number au WO2020160619
Patent description As animals, including humans, age, a number of complex reactions including Amadori reactions, Maillard reactions, and Schiff-base reactions lead to an increase in the concentration of advanced glycation end products in the cells. Such advanced glycation end products include reactive products that lead to cell damage, which is thought to be associated with age-related dysfunction of tissues and/or organs. Additionally, advanced glycation end products are also potentially associated with the development of morbidities within the ageing populations world-wide. Given the afore- mentioned dysfunction and morbidities within the ageing populations around the world, a need exists for a composition that will reduce the concentration of advanced glycation end products in a cell when administered in a therapeutically effective dose to a subject in need thereof and a method of using such a composition. The present disclosure relates to a glycation reducing composition and a method of use thereof.
See patent A GLYCATION REDUCING COMPOSITION See patent